Conference abstractPublished 15 Mar 2022
Comparison of Dabigatran with Warfarin in Treatment of Acute Deep Vein Thrombosis in View of Efficacy and Safety
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism. Dabigatran was proven to have similar effect on the prevention of recurrence of venous thromboembolism and a lower risk of bleeding compared to vitamin K antagonists. This study aimed to compare the safety and efficacy of Dabigatran with Warfarin in patients with DVT. Materials and Methods: A retrospective study in patients with DVT who received dabigatran 110 mg twice and warfarin 50 mg once in a day for treatment of DVT. Demographic details, drug treatment, medical history, presenting complains and diagnosis was recorded in CRF. Descriptive statistical analysis was done using MS Excel. Results: In total, 60 patients with DVT were divided into 2 treatment groups (30 to dabigatran and 30 to warfarin). Out of total patients, 15 (25%) patients from 31-40 age group and 37 (62%) were women seen higher prevalence. The duration of treatment was 6 months. Majority of them 32 (53.4%) had Poplitial femoral DVT. Dabigatran treatment group 26 (86.6%) showed better recanalization at the end of the 6-month treatment duration while in Warfarin there are 15 (50%) patients. All the parameters had significant differences except for patients who had pulmonary embolism even on medications. There was no patient in dabigatran group who had bleeding while 3 (10%) patients in warfarin group had bleeding. Conclusion: For the treatment of acute DVT, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfarin, and does not require laboratory monitoring. The findings of the study will give new insights into the selection of treatment regimens in patients with DVT.
Keywords
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Immune Disorders & Therapy
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Jalpa Suthar”
